Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Baxter
AstraZeneca
Express Scripts
McKinsey

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Cytisine


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Cytisine?

Cytisine is an investigational drug.

There have been 14 clinical trials for Cytisine. The most recent clinical trial was a Phase 3 trial, which was initiated on October 13th 2020.

The most common disease conditions in clinical trials are Behavior, Addictive, Inflammation, and HIV Infections. The leading clinical trial sponsors are Achieve Life Sciences, University of Auckland, New Zealand, and Istituto Di Ricerche Farmacologiche Mario Negri.

There are three hundred US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for Cytisine
TitleSponsorPhase
PeRiopEratiVE smokiNg cessaTion TrialPopulation Health Research InstitutePhase 2/Phase 3
Cytisine Compared to Combination NRT in Relapsed SmokersOttawa Heart Institute Research CorporationN/A
Comparative Effectiveness of Cystine Versus Nicotine Replacement TherapyMongolian National University of Medical SciencesPhase 3

See all Cytisine clinical trials

Clinical Trial Summary for Cytisine

Top disease conditions for Cytisine
Top clinical trial sponsors for Cytisine

See all Cytisine clinical trials

US Patents for Cytisine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Cytisine ⤷  Try it Free Methods and compositions for treating infection UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS) ⤷  Try it Free
Cytisine ⤷  Try it Free Use of neural cells derived from human pluripotent stem cells for the treatment of neurodegenerative diseases International Stem Cell Corporation (Carlsbad, CA) ⤷  Try it Free
Cytisine ⤷  Try it Free Nicotinic attenuation of CNS inflammation and autoimmunity Dignity Health (San Francisco, CA) ⤷  Try it Free
Cytisine ⤷  Try it Free Dietary supplements and formulations Eastern Vision Limited (Wanchai, HK) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Cytisine

Drugname Country Document Number Estimated Expiration Related US Patent
Cytisine World Intellectual Property Organization (WIPO) WO2014052836 2032-09-27 ⤷  Try it Free
Cytisine European Patent Office EP2961277 2033-02-15 ⤷  Try it Free
Cytisine Hong Kong HK1215358 2033-02-15 ⤷  Try it Free
Cytisine Japan JP2016508520 2033-02-15 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Baxter
AstraZeneca
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.